DeepTift develops advanced artificial intelligence pipelines designed to accelerate biomedical discovery, improve diagnostic systems, and enable next-generation healthcare technologies.
Deep learning models and graph-based algorithms designed to accelerate the discovery of novel therapeutic molecules.
Machine learning systems capable of identifying disease patterns from clinical data, imaging, and patient records.
In-silico drug discovery platforms integrating molecular simulation, generative models, and AI optimization.
AI-driven predictive models that support clinical decision making and patient risk assessment.